Scientia Ventures

Founded in 2006, Scientia Ventures is a venture capital firm based in New York. It invests in early to mid-stage technology companies focused on computational biology and chemistry, digitization of medicine, digital therapies, and innovative drug development within the life sciences sector.

John Dessouki

Principal

Jonathan Finn

General Partner

Harry Glorikian

General Partner

Rory Riggs

General Partner

9 past transactions

IntelinAir

Series B in 2021
IntelinAir is an aerial imagery analytics company focused on agriculture, delivering actionable intelligence from aerial data to help farmers and agricultural retailers improve efficiency, yields, and profitability. The company offers a crop intelligence and analytics platform that provides whole-field views, field prioritization, and timely monitoring to support data-driven decisions all season long. Its solutions enable users to assess current conditions, protect yield potential, and identify sustainability opportunities, while hardware and software tools support precise data collection and analysis from unmanned aerial vehicles.

Humanity

Seed Round in 2021
Humanity is a healthcare company founded in 2019 and headquartered in Boston, Massachusetts. It focuses on extending healthspan by developing a software application that provides users with information on interventions to mitigate the aging process. The application offers a subscription-based service that tracks key aging biomarkers, recovery, sleep duration, and activity levels. By analyzing this data, users can identify actions to slow aging and reduce the risk of related diseases. Through its innovative approach, Humanity aims to empower individuals to make informed decisions about their health and aging.

1910 Genetics

Seed Round in 2020
1910 Genetics is a biotechnology company leveraging artificial intelligence, computation, and biological automation to enhance drug discovery. It focuses on understanding diseases at a molecular level, initially demonstrated through its work on sickle cell anemia, to design and accelerate the development of small molecule and protein therapeutics.

X-Vax

Series A in 2019
X-Vax Technology is a biotechnology company established in 2015 and headquartered in Jupiter, Florida. Its primary focus is the preclinical and clinical development of vaccines targeting mucosal infections caused by pathogens, including herpes, influenza, tuberculosis, and HIV, which affect millions globally. X-Vax is known for its development of a herpes vaccine candidate based on a genetically altered HSV-2 virus, specifically designed to elicit a robust immune response by inducing antibodies that lead to the killing of infected cells. This innovative approach utilizes Fc receptor activating antibodies that facilitate antibody-dependent cell-mediated killing, aiming to provide effective protection against herpes types 1 and 2. Through its pioneering research, X-Vax intends to advance the field of vaccines and enhance immune responses against significant viral infections.

DeepBiome Therapeutics

Seed Round in 2019
Founded in 2017, DeepBiome Therapeutics develops a pioneering drug discovery platform that combines deep learning, microbiome analysis, and synthetic biology. This innovative approach enables the development of novel therapeutics targeting central nervous system disorders.

IntelinAir

Seed Round in 2017
IntelinAir is an aerial imagery analytics company focused on agriculture, delivering actionable intelligence from aerial data to help farmers and agricultural retailers improve efficiency, yields, and profitability. The company offers a crop intelligence and analytics platform that provides whole-field views, field prioritization, and timely monitoring to support data-driven decisions all season long. Its solutions enable users to assess current conditions, protect yield potential, and identify sustainability opportunities, while hardware and software tools support precise data collection and analysis from unmanned aerial vehicles.

Drumroll AI

Seed Round in 2014
Drumroll AI is a data science platform that leverages artificial intelligence and advanced algorithms to enhance data analysis efficiency. The company's insight analytics engine is designed to automate, accelerate, and augment the process of extracting meaningful information from raw data. By automating data preparation tasks and query creation, Drumroll AI enables both data experts and non-experts to focus on deriving valuable insights from their data.

LiquiGlide

Seed Round in 2014
LiquiGlide Inc., founded in 2012 and based in Cambridge, Massachusetts, specializes in the development of innovative liquid-impregnated coatings designed to facilitate the effortless movement of viscous liquids. As a pioneer in creating permanently wet slippery surfaces, LiquiGlide provides unique solutions that enhance the flow of liquids across various industries, including manufacturing, oil and gas, aviation, utilities, and food and beverage. The company's technology addresses the common challenges associated with moving thick liquids, offering a durable alternative that is unmatched in the market. LiquiGlide's products are utilized in diverse applications, ranging from health and beauty to household goods, making it a versatile player in the coatings industry.

Cristcot

Seed Round in 2010
Founded in 2008, Cristcot specializes in developing drug delivery systems focused on gastroenterology, neurology, and pain management. Its flagship product is Sephure, a disposable suppository applicator designed to facilitate hygienic administration of various medications for conditions such as constipation, digestive diseases, migraines, and palliative care.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.